Cơ Chế Tác Dụng : 
								
									ACR325 is developed for the treatment of Parkinson’s disease and psychoses, including bipolar disorder, for which disease existing therapies have only limited effect and considerable adverse side effects. ACR325 is a dopaminergic stabiliser, which has demonstrated promising results in disease models for motor functions and psychoses.								
								
									ACR325 is a dopaminergic stabiliser. The compound significantly increases the level of dopamine and noradrenalin in the forebrain and concurrently inhibits the over-activity of dopamine in other regions of the brain without unwanted inhibitory effect on motor activity.								
							
														
														
														
							
																					
								 Chỉ Định : 
								
									Investigated for use/treatment in affective disorders, bipolar disorders, and psychosis.